Content about Bevacizumab

February 15, 2012
Counterfeit Avastin circulating in U.S., FDA warns

Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.

January 27, 2012
FDA approves Pfizer's Inlyta for advanced kidney cancer

The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

November 18, 2011
FDA revokes breast cancer approval for Avastin

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

November 7, 2011
Reports: FDA finds manufacturing problems at Genentech plant

A new report from the Food and Drug Administration indicated that Roche division Genentech may not have followed proper procedures to prevent the contamination of certain drugs, according to published reports.

February 11, 2011
Lucentis improves vision among diabetes patients in trial

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

February 9, 2011
Genentech: Avastin boosts chances of progression-free survival among ovarian cancer patients

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

January 19, 2011
Genentech appeals FDA's plan to pull Avastin off market

Drug maker Genentech is hoping to keep a breast cancer treatment on the market as the Food and Drug Administration considers whether to revoke its approval for the disease, according to published reports.

December 16, 2010
FDA looks to pull the plug on Avastin's breast cancer indication

Just a few months after a Food and Drug Administration advisory committee recommended limiting the use of a Genentech drug designed to treat breast cancer, the regulatory agency is looking to revoke the approval altogether.

September 19, 2010
Genentech amends approval application for expanded use of Avastin

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

August 31, 2010
FDA expedites review of Alimera's Iluvien

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

July 20, 2010
FDA advisory committee recommends limiting use of Genentech breast cancer drug

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

June 22, 2010
FDA approves Lucentis for vision loss-related disease

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 15, 2010
Patient enrollment complete for lung cancer treatment trial

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

May 2, 2010
Study: Combination therapy may improve diabetic macular edema

A combination of a biotech drug and laser treatment may improve vision in patients with...

March 17, 2010
Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 11, 2010
Late-stage clinical trial of Avastin fails to meet expectations, Genentech says

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

February 24, 2010
Genentech reports positive clinical results in Avastin trial

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

February 23, 2010
Report projects breast cancer drug sales to exceed $1 billion

An investigational drug for treating breast cancer will garner sales of more than $1 billion...

© 2012 Drug Store News. All Rights Reserved.